TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 6B 12B 18B Q3 '24: 16.8B Q4 '24: 16.5B Q1 '25: 16.6B Q2 '25: 16.6B Q3 '25: 16.8B Q4 '25: 17.3B Q1 '26: 17.3B Q2 '26: 17.3B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 3.5B 7B 10.5B Q3 '24: 8.4B Q4 '24: 8.1B Q1 '25: 8.2B Q2 '25: 8.2B Q3 '25: 8.4B Q4 '25: 8.9B Q1 '26: 9B Q2 '26: 9.1B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-800M 0 800M 1.6B 2.4B Q3 '24: 482M Q4 '24: -303M Q1 '25: 434M Q2 '25: 894M Q3 '25: 1.8B Q4 '25: 2.2B Q1 '26: 2.3B Q2 '26: 1.6B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '24: -958M Q4 '24: -1.6B Q1 '25: -1.3B Q2 '25: -158M Q3 '25: 712M Q4 '25: 1.4B Q1 '26: 1.6B Q2 '26: 706M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 3B 6B 9B Q3 '24: 8.4B Q4 '24: 8.5B Q1 '25: 8.4B Q2 '25: 8.4B Q3 '25: 8.4B Q4 '25: 8.3B Q1 '26: 8.3B Q2 '26: 8.2B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 700M 1.4B 2.1B Q3 '24: 1.9B Q4 '24: 1.2B Q1 '25: 1.3B Q2 '25: 1.4B Q3 '25: 1.1B Q4 '25: 1.6B Q1 '26: 1.7B Q2 '26: 1.9B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

0 500M 1B 1.5B Q3 '24: 1.4B Q4 '24: 749M Q1 '25: 765M Q2 '25: 890M Q3 '25: 578M Q4 '25: 1.1B Q1 '26: 1.2B Q2 '26: 1.3B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q3 '24: -0.84 Q4 '24: -1.45 Q1 '25: -1.15 Q2 '25: -0.16 Q3 '25: 0.60 Q4 '25: 1.20 Q1 '26: 1.33 Q2 '26: 0.60 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.